This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Piedmont Pharmaceuticals, LLC, Bayer Healthcare LLC, Tria Specialty Products, LLC. Active years: 2003-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3 
1 out of 790 
1 out of 1 Years Active: 2003-2017
Title: **Kathleen G Palma: Innovator in Parasitic Control**
Introduction
Kathleen G Palma, an esteemed inventor based in McLeansville, North Carolina, has made significant contributions in the field of parasitic control. With a total of five patents to her name, she focuses on innovative methods for treating various ectoparasite infestations that affect both humans and animals.
Latest Patents
Among her most recent patents is the "Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent." This invention involves pharmaceutically acceptable compositions of imidacloprid designed for oral delivery, effectively controlling targeted parasites such as fleas, ticks, helminthes, and scabies. Another notable patent is "Methods and compositions for treating ectoparasite infestation," which details the use of fatty acid esters, like isopropyl myristate, combined with siloxanes to eradicate various ectoparasites that impact humans, animals, and plants, including head lice, fleas, and ticks.
Career Highlights
Kathleen has contributed her innovative expertise to companies such as Piedmont Pharmaceuticals and Tria Specialty Products. Her work in these organizations has been pivotal in developing advanced formulations and methods that address parasitic issues effectively.
Collaborations
Throughout her career, Kathleen has collaborated with notable individuals in the field such as William R Campbell and Neil E Paulsen. These partnerships have fostered a creative environment that supports groundbreaking research and development in parasitic treatment.
Conclusion
Kathleen G Palma's contributions reflect a dedicated commitment to tackling the challenges posed by parasites through innovation. Her patents not only showcase her inventiveness but also her desire to improve health outcomes for both humans and animals alike. As the landscape of parasitic control continues to evolve, innovations like those of Kathleen will undoubtedly play a crucial role in shaping future solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile